Chee Meng Lim

Mr. Chee Meng Lim is the Chief Revenue Officer of ACT Genomics Co., Ltd. He has over 20 years of experience in the medical device industry. In particular, his field of functional expertise includes general management, sales and marketing, clinical applications, customer service and technical support services.

‍

Prior to joining ACT Genomics, Mr. Lim was the General Manager for Rest-of-Asia and China for Oxford Immunotec, a company focused on infectious disease solutions. During his tenure at Oxford Immunotec, he was responsible for creating and executing business expansion strategies in emerging markets. In a prior life, Mr. Lim was responsible for leading the Southeast Asia region for Teleflex, achieving regional double-digit growth focusing on specific segments such as surgical, anesthesia, respiratory, and interventional radiology. Mr. Lim started his professional career selling hospital capital equipment for Hill-Rom International.

‍

Mr Lim received his Bachelor of Science in Applied Physics from National University of Malaysia.